Every Form 4 that Envista Holdings Corporation (NVST) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NVST and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NVST filings page.
Envista Holdings Corp (NVST) reported an insider transaction by Veronica Acurio, President, Orthodontics. On August 25, 2026, 7,710 shares of common stock were withheld at $27.47 per share to satisfy tax withholding obligations on vesting stock-settled Restricted Stock Units. After this tax-withholding disposition, Acurio directly holds 48,806 shares of Envista common stock.
Envista Holdings Corp (NVST) reported an insider equity event involving President, Diagnostics Robert Befidi. On 2026-08-25, 5,147 shares of common stock were withheld at $27.47 per share to satisfy tax withholding obligations upon the vesting of stock-settled Restricted Stock Units. After this tax-withholding disposition, Befidi directly holds 45,785 shares of Envista common stock.
Envista Holdings Corp (NVST) reported an insider equity transaction by Chief Financial Officer Eric D. Hammestax withholding obligations related to the vesting of stock-settled Restricted Stock Units. After this withholding transaction, Hammes directly holds 99,913 shares of Envista common stock.
Envista Holdings Corp (NVST) reported an insider equity-related transaction by Stefan Nilsson, President, Nobel Biocare. On 2026-08-25, 804 shares of common stock were withheld by the company to satisfy tax withholding obligations upon the vesting of stock-settled Restricted Stock Units. Following this non-market, tax-related disposition, Nilsson held 61,560 shares of Envista common stock directly.
Envista Holdings Corp (NVST) reported an insider transaction by Mischa Reis, SVP, Strategy & Business Development. On 2026-08-20, Reis sold 8,000 shares of common stock at $27.50 per share in an open market or private transaction under a previously adopted Rule 10b5-1 trading plan, and held 27,321 shares directly after the sale.
Envista Holdings Corp (NVST) reported that Chief Executive Officer Paul A. Keel received equity awards on 2026-08-18. He was granted 179,730 Restricted Stock Units that vest ratably over four years, each converting 1-for-1 into common stock, increasing his direct common stock holdings to 551,304 shares. He also received 159,900 Performance Share Units tied to performance over four years, with a payout range of 75%–125% of the target amount based on achievement of specified performance measures.
Envista Holdings Corp (symbol: NVST) is the issuer of record for a Form 4 filing submitted to the SEC.
Envista Holdings Corp Chief Executive Officer Paul A. Keel reported a routine tax-related share disposition. On the vesting of stock-settled restricted stock units, 12,811 shares of common stock were withheld to satisfy tax withholding obligations, at a value of $23.43 per share. After this non-market transaction, he directly holds 371,574 shares of Envista common stock.
Envista Holdings Corp director Wendy Carruthers reported an equity compensation grant in the form of Restricted Stock Units (RSUs). On May 19, 2026, she acquired 9,330 RSUs as an annual equity grant for her board service. The RSUs will vest on the first anniversary of the grant date and are payable in Envista common stock on a one-to-one basis. Following this grant, Carruthers directly holds 59,940 shares of Envista common stock.
TSINGOS CHRISTINE A reported acquisition or exercise transactions in this Form 4 filing.
Envista Holdings Corp director Christine A. Tsingos received an annual equity grant of 9,330 Restricted Stock Units (RSUs) on common stock. The award was granted at no cash cost to her and is compensation for her board service.
The RSUs will vest on the first anniversary of the grant date and are payable one-for-one in shares of Envista common stock. Following this grant, Tsingos directly holds 59,930 shares of Envista common stock, reflecting her equity stake as a director.
Jain Vivek reported acquisition or exercise transactions in this Form 4 filing.
Envista Holdings Corp director Vivek Jain received an equity award of 9,330 restricted stock units (RSUs). The RSUs were granted as annual compensation for his service on the board and will vest on the first anniversary of the grant date. Each RSU is payable in one share of Envista common stock upon vesting, bringing Jain’s directly held common stock (including granted RSUs) to 52,945 shares after this award.
GALLAHUE KIERAN reported acquisition or exercise transactions in this Form 4 filing.
Envista Holdings director Kieran Gallahue received an equity grant of 9,330 Restricted Stock Units as board compensation. The RSUs were awarded on May 19, 2026 at no cash purchase price and will vest on the first anniversary of the grant date.
Each RSU is payable in one share of Envista common stock, aligning the director’s compensation with shareholder interests over time. Following this grant, Gallahue directly holds a total of 54,010 shares of Envista common stock, including shares underlying the RSUs once they vest.
Pierce James Andrew reported acquisition or exercise transactions in this Form 4 filing.
Envista Holdings Corp director James Andrew Pierce received a grant of 9,330 Restricted Stock Units for his board service. These RSUs vest on the first anniversary of the grant date and are payable in Envista common stock on a one-to-one basis, bringing his direct holdings to 18,485 shares.
Raskas Daniel reported acquisition or exercise transactions in this Form 4 filing.
Envista Holdings Corp director Daniel Raskas received an equity award in the form of Restricted Stock Units. He was granted 9,330 RSUs of common stock at no purchase price for his service as a director. The RSUs vest on the first anniversary of the grant date, and his direct holdings increase to 54,010 shares.
Huennekens R Scott reported acquisition or exercise transactions in this Form 4 filing.
Envista Holdings Corp director R. Scott Huennekens received an equity grant of 12,585 Restricted Stock Units (RSUs) for his board service. The RSUs were granted at no cash cost and will vest on the first anniversary of the grant date.
Each RSU will be settled in one share of Envista common stock upon vesting, increasing his equity-based compensation stake over time. After this grant, Huennekens directly holds 82,105 shares of Envista common stock, reflecting his ongoing alignment with shareholders through stock-based pay.
Envista Holdings Corp Chief Financial Officer Eric D. Hammes reported multiple equity transactions. He received 29,225 Performance Share Units and 38,040 stock options that vest over three years, along with 16,055 restricted stock units that also vest annually over three years.
In a related tax-withholding transaction, 2,045 shares of common stock were withheld at $29.59 per share to cover taxes on vesting RSUs, rather than sold in the open market. After these transactions, his directly held common stock increased to 110,798 shares, with additional unvested equity awards outstanding.
Envista Holdings Corp reported insider equity awards for Veronica Acurio, President, Orthodontics. On the reported date, she received grants of 13,845 Performance Share Units and 18,020 stock options, along with a 7,605-share award of common stock in the form of restricted stock units.
The performance units may ultimately pay out between 0%-200% of the 13,845 target amount based on achievement of specified performance measures over a three-year period. The option grant and restricted stock units vest in equal installments on each anniversary of grant over three years, conditioned on continued service.
The filing also shows a disposition of 1,412 common shares at $29.59 per share to satisfy tax withholding obligations tied to vesting RSUs, a non-open-market transaction. After these transactions, Acurio directly held 56,516 shares of Envista common stock.
Envista Holdings Corp reported insider equity awards for executive Stefan Nilsson, President, Nobel Biocare. He received 13,845 Performance Share Units that may pay out from 0% to 200% of target based on three-year performance, and an option for 18,020 shares vesting over three years.
Nilsson was also granted 7,605 Restricted Stock Units, which vest ratably over three years and convert into common shares on a 1-for-1 basis. In a related move, 182 common shares were withheld and disposed of to cover tax obligations upon RSU vesting.
Envista Holdings Corp executive Mischa Reis reported mixed equity compensation activity. On February 25, Reis received 10,770 Performance Share Units that may vest over a three-year performance period, with actual payout ranging from 0% to 200% of this target amount based on performance certification.
On the same date, Reis was granted 14,020 stock options that vest in three equal annual installments, and 5,915 restricted stock units that also vest ratably over three years, each converting into one share of common stock. In connection with the vesting of previously granted RSUs, 2,976 shares of common stock were withheld at $29.59 per share to cover tax obligations, reducing open-market impact. After these transactions, Reis directly owned 35,321 shares of common stock.
Envista Holdings Corp General Counsel Mark E. Nance reported equity compensation changes and related tax withholding. On February 25, 2026, he received 23,070 Performance Share Units, which can pay out between 0%-200% of this target amount based on three-year performance measures.
He was also granted 30,040 stock options that vest in equal annual installments over three years, and 12,675 shares of common stock tied to Restricted Stock Units that vest ratably on each anniversary of the grant date over three years. To cover tax obligations from RSU vesting, 3,368 shares of common stock were withheld at $29.59 per share, reducing the need for a separate cash payment.
Envista Holdings Corp Chief Accounting Officer Faez C. Kaabi reported two equity-related transactions involving company common stock. On the same date, 4,964 shares were disposed of at $29.59 per share to satisfy tax withholding obligations tied to the vesting of previously granted stock-settled RSUs.
Kaabi also acquired 13,520 RSUs as a grant that will vest in three equal annual installments, each RSU converting into one share of common stock upon vesting, subject to continued service. Following these transactions, Kaabi directly owned 58,552 shares of Envista common stock.
Envista Holdings Corp CEO Paul A. Keel reported a mix of equity awards and a small tax‑related share disposition. He received 132,885 Performance Share Units, which can pay out between 0% and 200% of this target amount based on three‑year performance goals. He was also granted 115,320 stock options and 48,670 Restricted Stock Units, each scheduled to vest in equal installments over three years, contingent on continued service. To cover tax withholding on vested RSUs, 11,840 common shares were withheld at $29.59 per share, leaving him with 384,385 common shares directly owned.
Envista Holdings Corp reported that Robert Befidi, its President, Diagnostics, received several equity awards. He was granted 13,845 Performance Share Units, which can pay out between 0% and 200% of this target amount depending on performance over a three-year period.
He also received 18,020 employee stock options that vest in three equal annual installments, and 7,605 restricted stock units that likewise vest ratably over three years, all subject to continued service. Separately, 2,177 common shares were withheld at $29.59 per share to cover tax obligations on vesting RSUs, leaving him with 50,932 common shares directly owned.
Envista Holdings senior vice president of Strategy & Business Development Mischa Reis exercised stock options and sold the resulting shares on February 10, 2026. He exercised options for 4,041 shares at $19.04 and 5,634 shares at $15.97, then sold the same share amounts at $30 per share under a pre‑adopted Rule 10b5-1 trading plan, ending with 32,382 common shares held directly.
Envista Holdings Corp. President, Diagnostics Robert Befidi reported an automatic award of 998 notional shares linked to Envista stock on February 1, 2026. These units were credited to his Envista deferred contribution program at a reference price of $23.47 per share and convert one-for-one into common stock under the plan terms.
After this company contribution, Befidi holds 2,149 notional shares in the Envista stock fund within the Excess Contribution Program. The award consists of unfunded, notional units that reflect matching or non‑elective contributions, which vest over time based on service and anniversary dates.
Envista Holdings Corp executive Mischa Reis reported an annual deferred stock-based award through the company’s Executive Deferred Incentive Program (EDIP). On 02/01/2026, the EDIP Stock Fund credited 2,919 unfunded, notional shares of Envista common stock at a reference price of $21.71 per share, representing the company’s annual contribution.
The notional units convert into Envista common stock on a one-for-one basis and are 90% vested initially, with an additional 10% vesting each year on January 1 until Reis reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in Envista common shares. After this transaction, Reis beneficially owned 29,357 derivative securities tied to Envista stock under the EDIP.
Envista Holdings Corp Chief Financial Officer Form 4 filing reports a company contribution into a deferred compensation stock fund. On 02/01/2026, the CFO acquired 1,119 unfunded, notional shares in the Envista deferred contribution programs – Envista Stock Fund at $23.47 per share.
The notional shares convert on a one-for-one basis into Envista common stock and represent the company’s annual contribution to the ECP Stock Fund in the CFO’s Excess Contribution Program account. These contributions vest over time according to plan rules based on service and anniversaries of contributions.
Envista Holdings Corp. reported that Chief Executive Officer and director Paul A. Keel acquired derivative interests tied to company stock through an employee deferred compensation arrangement. On 02/01/2026, 4,091 notional shares were credited to his Envista deferred contribution programs – Envista Stock Fund at a reference price of $23.47 per share.
These unfunded, notional shares convert on a one-for-one basis into Envista common stock and represent the company’s annual contribution to the ECP Stock Fund in his account. The contribution amount is calculated using the closing price of Envista common stock on the last trading day of January, and vesting follows the program’s matching and non-elective contribution schedules.
Envista Holdings Corporation reported that General Counsel Mark E. Nance received a company contribution into the Envista deferred contribution programs’ Envista Stock Fund on 02/01/2026. The contribution equated to 2,006 unfunded, notional shares of Envista common stock at a reference price of $23.47 per share.
These notional shares convert into Envista common stock on a one-for-one basis and form part of the company’s Excess Contribution Program, which includes matching and non-elective contributions subject to vesting conditions based on service and time. Following this transaction, Nance’s ECP Stock Fund balance totaled 7,587 notional shares, held directly in his ECP account.
Envista Holdings Corp. Chief Accounting Officer Faez C. Kaabi reported a routine compensation-related transaction tied to the company’s deferred contribution programs. On February 1, 2026, the Envista Excess Contribution Program credited 1,186 unfunded, notional shares in the Envista Stock Fund to the reporting person’s account at a reference price of $23.47 per share. These notional units convert on a one-for-one basis into Envista common stock under the plan’s terms and represent the company’s annual contribution based on deferred compensation elections. Following this transaction, the reporting person holds 5,040 such notional derivative securities directly in the Envista Stock Fund within the deferred compensation plan, subject to the plan’s vesting schedules for matching and non-elective company contributions.
Envista Holdings executive Veronica Acurio, President, Orthodontics, reported a company contribution of 998 unfunded, notional shares tied to Envista common stock under her Excess Contribution Program account. The contribution was credited on February 1, 2026, using a reference price of $23.47 per notional share, and vests over service-based periods described in the plan.
Envista Holdings Corp (NVST) CEO and director Paul A. Keel reported a Form 4 transaction. On 11/01/2025, 54,097 shares of common stock were withheld at $20.35 per share to satisfy tax obligations upon the vesting of stock‑settled restricted stock units (Transaction Code F). Following this withholding, Keel beneficially owns 347,555 shares directly.